Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
  • Page of 1
Durovni B, Pinto M, Schecter M. AIDS case definitions in developing countries. Lancet. 1993 Oct 23;342(8878):1054. PubMed PMID: 8105285.
Saraceni V, da Cruz MM, Lauria Lde M, Durovni B. Trends and characteristics of AIDS mortality in the Rio de Janeiro city after the introduction of highly active antiretroviral therapy. Braz J Infect Dis. 2005 Jun;9(3):209-15. doi: 10.1590/s1413-86702005000300003. Epub 2005 Oct 3. PubMed PMID: 16224627.
Soares EC, Pacheco AG, Mello FC, Durovni B, Chaisson RE, Cavalcante SC. Improvements in treatment success rates with directly observed therapy in Rio de Janeiro City. Int J Tuberc Lung Dis. 2006 Jun;10(6):690-5. PubMed PMID: 16776458.
Soares EC, Saraceni V, Lauria Lde M, Pacheco AG, Durovni B, Cavalcante SC. Tuberculosis as a disease defining acquired immunodeficiency syndrome: ten years of surveillance in Rio de Janeiro, Brazil. J Bras Pneumol. 2006 Sep-Oct;32(5):444-8. PubMed PMID: 17268749.
Moulton LH, Golub JE, Durovni B, Cavalcante SC, Pacheco AG, Saraceni V, King B, Chaisson RE. Statistical design of THRio: a phased implementation clinic-randomized study of a tuberculosis preventive therapy intervention. Clin Trials. 2007;4(2):190-9. doi: 10.1177/1740774507076937. PubMed PMID: 17456522.
Rapparini C, Saraceni V, Lauria LM, Barroso PF, Vellozo V, Cruz M, Aquino S, Durovni B. Occupational exposures to bloodborne pathogens among healthcare workers in Rio de Janeiro, Brazil. J Hosp Infect. 2007 Feb;65(2):131-7. doi: 10.1016/j.jhin.2006.09.027. Epub 2006 Dec 18. PubMed PMID: 17178428.
Cavalcante SC, Soares EC, Pacheco AG, Chaisson RE, Durovni B. Community DOT for tuberculosis in a Brazilian favela: comparison with a clinic model. Int J Tuberc Lung Dis. 2007 May;11(5):544-9. PubMed PMID: 17439679.
Golub JE, Saraceni V, Cavalcante SC, Pacheco AG, Moulton LH, King BS, Efron A, Moore RD, Chaisson RE, Durovni B. The impact of antiretroviral therapy and isoniazid preventive therapy on tuberculosis incidence in HIV-infected patients in Rio de Janeiro, Brazil. AIDS. 2007 Jul 11;21(11):1441-8. doi: 10.1097/QAD.0b013e328216f441. PubMed PMID: 17589190; PubMed Central PMCID: PMC3063947.
Saraceni V, King BS, Cavalcante SC, Golub JE, Lauria LM, Moulton LH, Chaisson RE, Durovni B. Tuberculosis as primary cause of death among AIDS cases in Rio de Janeiro, Brazil. Int J Tuberc Lung Dis. 2008 Jul;12(7):769-72. PubMed PMID: 18544202; PubMed Central PMCID: PMC3731736.
Pacheco AG, Durovni B, Cavalcante SC, Lauria LM, Moore RD, Moulton LH, Chaisson RE, Golub JE. AIDS-related tuberculosis in Rio de Janeiro, Brazil. PLoS One. 2008 Sep 10;3(9):e3132. doi: 10.1371/journal.pone.0003132. PubMed PMID: 18781195; PubMed Central PMCID: PMC2518952.
Golub JE, Durovni B, King BS, Cavalacante SC, Pacheco AG, Moulton LH, Moore RD, Chaisson RE, Saraceni V. Recurrent tuberculosis in HIV-infected patients in Rio de Janeiro, Brazil. AIDS. 2008 Nov 30;22(18):2527-33. doi: 10.1097/QAD.0b013e328311ac4e. PubMed PMID: 19005276; PubMed Central PMCID: PMC2603140.
Pacheco AG, Saraceni V, Tuboi SH, Moulton LH, Chaisson RE, Cavalcante SC, Durovni B, Faulhaber JC, Golub JE, King B, Schechter M, Harrison LH. Validation of a hierarchical deterministic record-linkage algorithm using data from 2 different cohorts of human immunodeficiency virus-infected persons and mortality databases in Brazil. Am J Epidemiol. 2008 Dec 1;168(11):1326-32. doi: 10.1093/aje/kwn249. Epub 2008 Oct 9. PubMed PMID: 18849301; PubMed Central PMCID: PMC2638543.
Dowdy DW, Lourenço MC, Cavalcante SC, Saraceni V, King B, Golub JE, Bishai D, Durovni B, Chaisson RE, Dorman SE. Impact and cost-effectiveness of culture for diagnosis of tuberculosis in HIV-infected Brazilian adults. PLoS One. 2008;3(12):e4057. doi: 10.1371/journal.pone.0004057. Epub 2008 Dec 29. PubMed PMID: 19129940; PubMed Central PMCID: PMC2614861.
Conde MB, Melo FA, Marques AM, Cardoso NC, Pinheiro VG, Dalcin Pde T, Machado Junior A, Lemos AC, Netto AR, Durovni B, Sant'Anna CC, Lima D, Capone D, Barreira D, Matos ED, Mello FC, David FC, Marsico G, Afiune JB, Silva JR, Jamal LF, Telles MA, Hirata MH, Dalcolmo MP, Rabahi MF, Cailleaux-Cesar M, Palaci M, Morrone N, Guerra RL, Dietze R, Miranda SS, Cavalcante SC, Nogueira SA, Nonato TS, Martire T, Galesi VM, Dettoni Vdo V. III Brazilian Thoracic Association Guidelines on tuberculosis. J Bras Pneumol. 2009 Oct;35(10):1018-48. doi: 10.1590/s1806-37132009001000011. Review. PubMed PMID: 19918635.
Cavalcante SC, Durovni B, Barnes GL, Souza FB, Silva RF, Barroso PF, Mohan CI, Miller A, Golub JE, Chaisson RE. Community-randomized trial of enhanced DOTS for tuberculosis control in Rio de Janeiro, Brazil. Int J Tuberc Lung Dis. 2010 Feb;14(2):203-9. PubMed PMID: 20074412; PubMed Central PMCID: PMC3812056.
Miller AC, Golub JE, Cavalcante SC, Durovni B, Moulton LH, Fonseca Z, Arduini D, Chaisson RE, Soares EC. Controlled trial of active tuberculosis case finding in a Brazilian favela. Int J Tuberc Lung Dis. 2010 Jun;14(6):720-6. PubMed PMID: 20487610; PubMed Central PMCID: PMC6203956.
Eldred LJ, Churchyard G, Durovni B, Godfrey-Faussett P, Grant AD, Getahun H, Chaisson RE. Isoniazid preventive therapy for HIV-infected people: evidence to support implementation. AIDS. 2010 Nov;24 Suppl 5:S1-3. doi: 10.1097/01.aids.0000391009.95149.ec. PubMed PMID: 21079422.
Durovni B, Cavalcante SC, Saraceni V, Vellozo V, Israel G, King BS, Cohn S, Efron A, Pacheco AG, Moulton LH, Chaisson RE, Golub JE. The implementation of isoniazid preventive therapy in HIV clinics: the experience from the TB/HIV in Rio (THRio) study. AIDS. 2010 Nov;24 Suppl 5:S49-56. doi: 10.1097/01.aids.0000391022.95412.a6. PubMed PMID: 21079428; PubMed Central PMCID: PMC3066070.
Pacheco AG, Saraceni V, Tuboi SH, Lauria LM, Moulton LH, Faulhaber JC, King B, Golub JE, Durovni B, Cavalcante S, Harrison LH, Chaisson RE, Schechter M. Estimating the extent of underreporting of mortality among HIV-infected individuals in Rio de Janeiro, Brazil. AIDS Res Hum Retroviruses. 2011 Jan;27(1):25-8. doi: 10.1089/aid.2010.0089. Epub 2010 Oct 7. PubMed PMID: 20929394; PubMed Central PMCID: PMC3026651.
Saraceni V, Pacheco AG, Golub JE, Vellozo V, King BS, Cavalcante SC, Eldred L, Chaisson RE, Durovni B. Physician adherence to guidelines for tuberculosis and HIV care in Rio de Janeiro, Brazil. Braz J Infect Dis. 2011 May-Jun;15(3):249-52. doi: 10.1016/s1413-8670(11)70184-2. PubMed PMID: 21670926.
Dowdy DW, Israel G, Vellozo V, Saraceni V, Cohn S, Cavalcante S, Chaisson RE, Golub JE, Durovni B. Quality of life among people treated for tuberculosis and human immunodeficiency virus in Rio de Janeiro, Brazil. Int J Tuberc Lung Dis. 2013 Mar;17(3):345-7. doi: 10.5588/ijtld.12.0123. Epub 2013 Jan 14. PubMed PMID: 23321341; PubMed Central PMCID: PMC3718256.
Durovni B, Saraceni V, Moulton LH, Pacheco AG, Cavalcante SC, King BS, Cohn S, Efron A, Chaisson RE, Golub JE. Effect of improved tuberculosis screening and isoniazid preventive therapy on incidence of tuberculosis and death in patients with HIV in clinics in Rio de Janeiro, Brazil: a stepped wedge, cluster-randomised trial. Lancet Infect Dis. 2013 Oct;13(10):852-8. doi: 10.1016/S1473-3099(13)70187-7. Epub 2013 Aug 16. PubMed PMID: 23954450; PubMed Central PMCID: PMC3899698.
Soares EC, Vollmer WM, Cavalcante SC, Pacheco AG, Saraceni V, Silva JS, Neves GR, Golub JE, Efron AR, Durovni B, Chaisson RE. Tuberculosis control in a socially vulnerable area: a community intervention beyond DOT in a Brazilian favela. Int J Tuberc Lung Dis. 2013 Dec;17(12):1581-6. doi: 10.5588/ijtld.13.0152. PubMed PMID: 24200272.
Kass NE, DeLuca AN, Coetzee L, Simwinga M, Churchyard GJ, Ayles H, Beyers N, Godfrey-Faussett P, Durovni B, Chaisson RE, Eldred LJ. Applying ethical principles to international community-based research: a case study from the Consortium to Respond Effectively to the AIDS-TB Epidemic (CREATE) . IRB. 2014 May-Jun;36(3):1-8. PubMed PMID: 24946506.
Durovni B, Saraceni V, Cordeiro-Santos M, Cavalcante S, Soares E, Lourenço C, Menezes A, van den Hof S, Cobelens F, Trajman A. Operational lessons drawn from pilot implementation of Xpert MTB/Rif in Brazil. Bull World Health Organ. 2014 Aug 1;92(8):613-7. doi: 10.2471/BLT.13.131409. Epub 2014 May 1. PubMed PMID: 25177076; PubMed Central PMCID: PMC4147406.
Dowdy DW, Golub JE, Saraceni V, Moulton LH, Cavalcante SC, Cohn S, Pacheco AG, Chaisson RE, Durovni B. Impact of isoniazid preventive therapy for HIV-infected adults in Rio de Janeiro, Brazil: an epidemiological model. J Acquir Immune Defic Syndr. 2014 Aug 15;66(5):552-8. doi: 10.1097/QAI.0000000000000219. PubMed PMID: 24853308; PubMed Central PMCID: PMC4257469.
Saraceni V, Durovni B, Cavalcante SC, Cohn S, Pacheco AG, Moulton LH, Chaisson RE, Golub JE. Survival of HIV patients with tuberculosis started on simultaneous or deferred HAART in the THRio cohort, Rio de Janeiro, Brazil. Braz J Infect Dis. 2014 Sep-Oct;18(5):491-5. doi: 10.1016/j.bjid.2014.02.004. Epub 2014 Apr 27. PubMed PMID: 24780362.
Saraceni V, Durovni B, Pacheco AG, Chaisson RE, Golub JE. Reply to "at the crossroads between early or delayed antiretroviral therapy initiation during TB/HIV coinfection". Braz J Infect Dis. 2014 Sep-Oct;18(5):578-9. doi: 10.1016/j.bjid.2014.07.001. Epub 2014 Aug 7. PubMed PMID: 25108220.
Cordeiro-Santos M, Trajman A, Cobelens F, Durovni B, Gonçalves M, Bührer-Sékula S, Saraceni V. Tuberculosis infection control: potential benefit of a new rapid tuberculosis test in a human immunodeficiency virus/AIDS reference hospital. Infect Control Hosp Epidemiol. 2014 Sep;35(9):1206-7. doi: 10.1086/677643. PubMed PMID: 25111939.
Saraceni V, Cohn S, Cavalcante SC, Pacheco AG, Moulton LH, Chaisson RE, Durovni B, Golub JE. Prevalent tuberculosis at HIV diagnosis in Rio de Janeiro, Brazil: the TB/HIV in Rio (THRio) Cohort. J Acquir Immune Defic Syndr. 2014 Sep 1;67(1):98-101. doi: 10.1097/QAI.0000000000000247. PubMed PMID: 24933097; PubMed Central PMCID: PMC4497547.
Trajman A, Durovni B, Saraceni V, Cordeiro-Santos M, Cobelens F, van den Hof S. High positive predictive value of Xpert in a low rifampicin resistance prevalence setting. Eur Respir J. 2014 Dec;44(6):1711-3. doi: 10.1183/09031936.00115514. Epub 2014 Sep 3. PubMed PMID: 25186257.
Azadi M, Bishai DM, Dowdy DW, Moulton LH, Cavalcante S, Saraceni V, Pacheco AG, Cohn S, Chaisson RE, Durovni B, Golub JE. Cost-effectiveness of tuberculosis screening and isoniazid treatment in the TB/HIV in Rio (THRio) Study. Int J Tuberc Lung Dis. 2014 Dec;18(12):1443-8. doi: 10.5588/ijtld.14.0108. PubMed PMID: 25517809; PubMed Central PMCID: PMC5451319.
Golub JE, Cohn S, Saraceni V, Cavalcante SC, Pacheco AG, Moulton LH, Durovni B, Chaisson RE. Long-term protection from isoniazid preventive therapy for tuberculosis in HIV-infected patients in a medium-burden tuberculosis setting: the TB/HIV in Rio (THRio) study. Clin Infect Dis. 2015 Feb 15;60(4):639-45. doi: 10.1093/cid/ciu849. Epub 2014 Nov 2. PubMed PMID: 25365974; PubMed Central PMCID: PMC4366579.
Trajman A, Durovni B, Saraceni V, Menezes A, Cordeiro-Santos M, Cobelens F, Van den Hof S. Impact on Patients' Treatment Outcomes of XpertMTB/RIF Implementation for the Diagnosis of Tuberculosis: Follow-Up of a Stepped-Wedge Randomized Clinical Trial. PLoS One. 2015;10(4):e0123252. doi: 10.1371/journal.pone.0123252. eCollection 2015. PubMed PMID: 25915745; PubMed Central PMCID: PMC4411054.
What would you like to do?
  • Page of 1